• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Delcath Systems, Inc.

    Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems to Host Third Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems to Host Second Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
    From Delcath Systems, Inc.
    Via Business Wire
    Tickers DCTH
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.